We found that IDH1-mutant GBM cells are sensitive to different epigenetic enzyme inhibitors such as DNMT inhibitor 5-azacitidine, HMT inhibitor chaetocin, KDM inhibitor GSK-J4, and HDAC inhibitor belinostat. Here, IDH1 is linked to glioblastoma.